Status:
COMPLETED
Rapid Diagnostic Test for Septic Arthritis
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Juvenile Idiopathic Arthritis
Arthritis, Septic
Eligibility:
All Genders
3-16 years
Brief Summary
Diagnostic Validation Study of a Test Based on the Analysis of the Proteome by Mass Spectrometry for the Diagnosis of Septic Arthritis in Children Under 16 Years of Age
Detailed Description
Arthritis is an inflammation of the joints that can have many causes. In children, septic arthritis (SA) is the most common cause of acute arthritis (around 45% of cases). Juvenile Idiopathic Arthriti...
Eligibility Criteria
Inclusion
- Patients \>3 months of age \<16 years of age
- Hospitalized for arthritis that started less than 6 weeks ago or patients with diagnosed inflammatory arthritis whose clinical course suggests bacterial superinfection
- Indication of a joint puncture for diagnostic purposes, confirmed by a senior physician after study of all available clinical and biological elements.
- Holders of parental authority who have accepted the participation of their children
- Patients benefiting from a social security scheme (excluding AME)
Exclusion
- Contraindications to joint puncture
Key Trial Info
Start Date :
May 6 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 6 2022
Estimated Enrollment :
274 Patients enrolled
Trial Details
Trial ID
NCT04460144
Start Date
May 6 2021
End Date
December 6 2022
Last Update
January 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Robert Debre Hospital
Paris, France, 75019